- “Cancer survivor loses sense of taste to treatment, but says life is sweeter.” Our own Mahesh Kudrimoti, MD, was highlighted for his work with a patient in the Markey Cancer Center Annual Report.
Vivek M. Rangnekar, PhD, is a faculty member of the Radiation Oncology department. His laboratory studies the molecular cross-talk between oncogenes and tumor suppressor genes in an effort to tilt the balance in favor of tumor suppressor function. The strategy is to utilize the inherent strengths of the tumor against itself to specifically target cell survival mechanisms that are common to diverse cancers while leaving the normal host cells unharmed.
William H. St. Clair, MD, PhD, is a faculty member of the Radiation Oncology department. His laboratory addresses the fundamental mechanisms by which radiation-induced cytokine production contributes to normal tissue injury and cancer progression in order to develop novel strategies for intervention, and to identify mechanistic based novel therapeutic agents and translate them into clinical applications.